AACR Annual Meeting 2018


On Saturday, April 14, 2018, a full program of Educational Sessions, Methods Workshops, and Special Sessions will be presented beginning at 8 a.m. The Opening Ceremony and the Opening Plenary Session will take place on Sunday morning, April 15. The meeting will conclude at 1:45 p.m. on Wednesday, April 18.

The AACR Online Proceedings/Itinerary Planner is now available. Users can browse and search all presentations on the Annual Meeting program (including regular abstracts) and select results to create a personal schedule for the meeting. While the titles of the regular abstracts are available through the Itinerary Planner, the full text of the abstracts will not be posted until Wednesday, March 14.

Please note that the Online Proceedings/Itinerary Planner does not yet contain the complete listing of Educational Sessions and Methods Workshops. The most up-to-date listing of these programs can be found below.

Educational Sessions 
Saturday, April 14, 2018

  • Advances in Cancer Vaccines
  • Autoimmunity Meets Tumor Immunity on the Road to Nucleic Acids Sensing
  • Autophagy in Cancer Therapy
  • Basket Trials for Precision Oncology
  • Big Data, Deep Learning, and AI Methods for Cancer Analysis
  • Biosimilars in Oncology: Key Topics of Interest
  • Cancer Evolution: Biologic and Clinical Significance of Intratumoral Heterogeneity
  • Cancer Genomics to Targeted Therapies in Thyroid Cancer
  • Cancer Immunology for Nonimmunologists
  • Cancer Immunology for Nonimmunologists: Roundtable Discussions
  • Cancer Prevention and Screening in LMIC
  • Common Statistical Errors and Mistakes in Cancer Research: How to Avoid Them
  • Computational Methods and Resources for Immunogenomics and Immune Therapy
  • Computational Methods for Cancer Genomics Research
  • Convergence of Theoretical Physics Approaches to Cancer
  • Co-stimulation and Co-inhibition in T Cell-Mediated Immunity
  • Development of Brain Penetrant Inhibitors: From Genomics to the Clinic
  • From Chemistry to the Clinic: Part 1 - Chemical Probes for Identifying and Validating Drug Targets
  • From Chemistry to the Clinic: Part 2 - Lead Optimization in Cancer Drug Discovery and Development, Multifactorial Optimization from Early Hits to Drug Candidates 
  • From Chemistry to the Clinic: Part 3 - Approaches to Drug Design for Neuro-oncology
  • Frontiers in Personalized Immunotherapy of Hematologic Malignancies
  • Genetic, Epigenetic, and Cellular Context Driving Pediatric Brain
  • Hijacking the Epigenome in Cancer: Challenges and Opportunities
  • Impact of the Microbiome in Cancer Immunity
  • Metabolic Landscapes and Reprogramming for Cancer Therapy
  • Methods for Translational Research to Address Cancer Health Disparities
  • Modeling Tumor Suppression in the Mouse
  • New Developments in the Treatment of Metastatic Colorectal Cancer
  • New Insights into the Biology and Treatment of Virus-Associated Malignancies
  • NGS Methods for Tumor Detection and Response Prediction
  • No More "Triple-Negative Breast Cancer": Molecular Classification and Personalized Therapy
  • Novel Methods to Dissect the Genome and the Epigenome
  • The Obesity Paradox and Cancer
  • Old and New Puzzles in the Genetic Epidemiology of Cancer
  • Opportunities in Drugging Protein-Protein Interactions Using Inhibitors and Degraders
  • Pancreatic Cancer Prevention
  • Predictors and Mechanisms of Success or Failure of Immunotherapy
  • Quantitative Methods for Characterization of Tumor Evolution
  • Recent Advances and Opportunities in Small Cell Lung Cancer (SCLC) Research
  • Response and Resistance to CDK4/6 Inhibitors in Breast Cancer
  • Rethinking Immunotherapeutic Approaches to Pediatric Solid Malignancies
  • Revisiting Vitamin C as an Epigenetic Therapeutic
  • RNA Metabolism in Cancer
  • Single-Cell Analysis of the Cancer Epigenome and Transcriptome
  • Translational Control of Cancer
  • The Use and Abuse of Chemical Probes: Ensuring Best Practice for Interrogating Biology and Target Validation
  • What Can We Learn about Cancer by Combining Germline and Somatic Data?

Methods Workshops 
Saturday, April 14, 2018

  • Advances in Patient-Derived Xenograft Modeling in Cancer
  • Assessing the T Cell Repertoire in Clinical Trials
  • Cancer Modeling in the CRISPR Age
  • Characterizing the PreCancer Genome: Identification of Early Drivers
  • Clinical Trial Design Part 1: Dose-Finding
  • Clinical Trial Design Part 2: Clinical Trial Design for Targeted Therapies
  • Clinical Trial Design Part 3: Trials Utilizing Combination Therapies
  • Knowledgebases for Precision Medicine: Variant Interpretation and Clinical Trial Matching
  • Liquid Biopsy Meets Cancer Epigenomics
  • Methods of Evaluation of Immunologic Landscape of Tumors
  • Multiplex Imaging of Tumor Tissues: Techniques and Data Analysis
  • NCI's UH2/UH3 Novel Assay Development Program
  • Oncology Biomarker Detection, Characterization, and Quantification by Mass Spectrometry 
  • Tracking Tumor Metabolism in Action

Top of page